How much does gemtuzumab/gemtuzumab (MYLOTARG) cost?

Gemtuzumab/Gemtuzumab (MYLOTARG) is a drug used to treat acute myeloid leukemia (AML). AMLIt is a malignant neoplastic disease that originates from immature myeloid cells in the bone marrow. It usually manifests as the rapid proliferation of abnormal white blood cells in the blood, causing the body to be unable to produce healthy blood cells normally.

Gemtuzumab/GemtuzumabIt is not currently on the market in China, so it cannot be included in medical insurance. Patients cannot purchase it domestically and need to purchase it through overseas channelsGemtuzumab/Gemtuzumab. Foreign Gemtuzumab/Gemtuzumab is only Pfizer’s original drug, which is expensive, and the cheaper ones are mainly Turkish original drugs. The price of the drug is around 45,000 yuan, and the price of the original drug in Hong Kong, China is around 65,000 yuan, and the ingredients and efficacy of the original drug are consistent.

Gemtuzumab/Gemtuzumab has a unique mechanism of action. It is a monoclonal antibody drug that specifically binds to the CD33 antigen, which is a protein on the surface of AML cells. Once gemtuzumab/gemtuzumab binds to CD33 antigen, it activates host immune cells, such as natural killer cells ( pan>NK cells) and macrophages, thereby guiding them to attack and killCD33positiveAML cells. This unique mechanism of action makes gemtuzumab/gemtuzumaban important tool in the treatment ofAML.

Overall,Gemtuzumab/GemtuzumabIt is an important AML therapeutic drug, and its mechanism of specifically binding and activating the immune system provides a promising approach to the treatment of this serious disease. However, before using Gemtuzumab/Gemtuzumab, patients should consult their doctor for a detailed treatment plan and possible risks and benefits.